Cargando…
The effect of aldosterone and aldosterone blockade on the progression of chronic kidney disease: a randomized placebo-controlled clinical trial
The progression of chronic kidney disease (CKD) cannot be completely inhibited. We first explored factors contributing to CKD progression in patients with CKD in a prospective observational study. In the next phase, we focused on the effects of aldosterone, conducting a single-blinded placebo-contro...
Autores principales: | Minakuchi, Hitoshi, Wakino, Shu, Urai, Hidenori, Kurokochi, Arata, Hasegawa, Kazuhiro, Kanda, Takeshi, Tokuyama, Hirobumi, Itoh, Hiroshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7538950/ https://www.ncbi.nlm.nih.gov/pubmed/33024237 http://dx.doi.org/10.1038/s41598-020-73638-4 |
Ejemplares similares
-
NNMT activation can contribute to the development of fatty liver disease by modulating the NAD(+) metabolism
por: Komatsu, Motoaki, et al.
Publicado: (2018) -
High Basolateral Glucose Increases Sodium-Glucose Cotransporter 2 and Reduces Sirtuin-1 in Renal Tubules through Glucose Transporter-2 Detection
por: Umino, Hiroyuki, et al.
Publicado: (2018) -
The significance of NAD + metabolites and nicotinamide N-methyltransferase in chronic kidney disease
por: Takahashi, Rina, et al.
Publicado: (2022) -
A Case Report of Autosomal Dominant Polycystic Kidney Disease Under
Peritoneal Dialysis With Cyst Infection and Culture-Positive Peritoneal
Fluid
por: Yasuda, Itaru, et al.
Publicado: (2019) -
Ghrelin Protects against Renal Damages Induced by Angiotensin-II via an Antioxidative Stress Mechanism in Mice
por: Fujimura, Keiko, et al.
Publicado: (2014)